Company Search:
Advanced Search
Sponsored Links
Hualan Biological Engineering Inc Company Snapshot
Hualan Biological Engineering Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Hualan Biological Engineering Inc with three other companies in this sector in China: China Biologic Products Holdings Inc (2018 sales of 3.09 billion Chinese Renmimbi [US$439.43 million] of which 32% was Human Albumin), Beijing Tiantan Biologic. (2.93 billion Chinese Renmimbi [US$416.65 million] of which 100% was Biological products industry), and Tonghua Dongbao Medicines Company Limited (2.69 billion Chinese Renmimbi [US$382.06 million] of which 87% was Pharmaceutical).

Sales Analysis. Hualan Biological Engineering Inc reported sales of 3.22 billion Chinese Renmimbi (US$457.28 million) for the year ending December of 2018. This represents an increase of 35.8% versus 2017, when the company's sales were 2.37 billion Chinese Renmimbi. Sales at Hualan Biological Engineering Inc have increased during each of the previous five years (and since 2013, sales have increased a total of 188%). Sales of Vaccine Products saw an increase that was more than double the company's growth rate: sales were up 183.9% in 2018, from 280.98 million Chinese Renmimbi to 797.74 million Chinese Renmimbi.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Hualan Biological Engineering Inc
  Stock Performance Chart for Hualan Biological Engineering Inc
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 33.40
(Figures in Chinese Renmimbi)
1 Week -0.2%   13 Weeks -7.0%  
4 Weeks 2.0%   52 Weeks 32.6%  
Hualan Biological Engineering Inc Key Data:
  Ticker: 002007 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 3,216,894,848
(Year Ending Jan 2019).
Employees: 2,144
  Currency: Chinese Renmimbi Market Cap: 46,862,171,268
  Fiscal Yr Ends: December Shares Outstanding: 1,403,059,020
  Share Type: A Shares Closely Held Shares: 734,197,778
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.